keyword
https://read.qxmd.com/read/38646073/infolding-of-evolut-pro-during-transcatheter-aortic-valve-implantation-and-bailout-by-post-balloon-dilation-a-case-report
#21
Kengo Tosaka, Ryo Ninomiya, Tetsuya Fusazaki, Yoshihiro Morino
UNLABELLED: An 89-year-old man with symptomatic severe aortic stenosis underwent transcatheter aortic valve implantation due to old age and a history of coronary artery bypass grafting. Computed tomography showed a tricuspid aortic valve and severe calcification at the aortic valve annulus, with a perimeter of 88.7 mm. The 34-mm Evolut PRO+ (Medtronic Inc., Minneapolis, MN, USA) was selected. After balloon aortic valvuloplasty, deployment of the Evolut PRO+ was attempted, but significant expansion failure was observed...
April 2024: Journal of Cardiology Cases
https://read.qxmd.com/read/38645290/transcatheter-edge-to-edge-mitral-valve-repair-in-a-patient-with-anderson-fabry-disease
#22
Mohamed Elwashahy, Jason Sharp, Dennis Wang, Tuan Nguyen-Dang, Jorge Moragues, Edward J F Danson
Severe degenerative mitral regurgitation (DMR) is one cardiac manifestation of the multiorgan metabolic enzyme disorder Anderson-Fabry Disease (AFD). Although DMR is normally managed surgically, many patients with AFD are unsuitable for this. We present the first case of mitral transcatheter edge-to-edge repair in a patient with AFD.
April 3, 2024: JACC. Case reports
https://read.qxmd.com/read/38644861/response-of-heterologously-expressed-pressure-sensor-actuator-modulator-macromolecule-to-external-mechanical-stress
#23
JOURNAL ARTICLE
Subrata Batabyal, Chinenye Idigo, Darryl Narcisse, Adnan Dibas, Samarendra Mohanty
Cells from different organs in the body experience a range of mechanical and osmotic pressures that change in various diseases, including neurological, cardiovascular, ophthalmological, and renal diseases. Here, we demonstrate the use of an engineered Sensor-Actuator-Modulator (SAM) of microbial origin derived from a mechanosensitive channel of large conductance (MscL) for sensing external mechanical stress and modulating activities of mammalian cells. SAM is reliably expressed in the mammalian cell membrane and acts as a tension-activated pressure release valve...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38644254/-short-term-efficacy-and-safety-of-cardiac-contractility-modulation-in-patients-with-heart-failure
#24
JOURNAL ARTICLE
Y K Guo, S Shang, T H Sun, Y Q Fan, Jiasuoer Xiaokereti, Kela TuErhong Zu, X Yang, L Zhang, Y D Li, Y M Lu, J H Zhang, Q Xing, X H Zhou, B P Tang
Objective: To investigate the short-term efficacy and safety of cardiac contractility modulation (CCM) in patients with heart failure. Methods: This was a cross-sectional study of patients with heart failure who underwent CCM placement at the First Affiliated Hospital of Xinjiang Medical University from February to June 2022. With a follow-up of 3 months, CCM sensation, impedance, percent output, and work time were monitored, and patients were compared with pre-and 3-month postoperative left ventricular ejection fraction (LVEF) values, and 6-minute walk test distance and New York Heart Association (NYHA) cardiac function classification, and the occurrence of complications was recorded...
April 24, 2024: Zhonghua Xin Xue Guan Bing za Zhi
https://read.qxmd.com/read/38644167/chronic-active-myocarditis-after-transapical-transcatheter-aortic-valve-implantation
#25
JOURNAL ARTICLE
Yuta Kobayashi, Toshiyuki Nagai, Kiwamu Kamiya, Satonori Tsuneta, Yasushige Shingu, Kento Wakabayashi, Kohsuke Kudo, Yoshihiro Matsuno, Satoru Wakasa, Toshihisa Anzai
No abstract text is available yet for this article.
April 20, 2024: Circulation Journal: Official Journal of the Japanese Circulation Society
https://read.qxmd.com/read/38644069/management-and-outcomes-of-pregnant-women-with-cardiovascular-diseases-in-a-cardio-obstetric-team
#26
JOURNAL ARTICLE
Marjorie Richardson, Jean Philippe Bonnet, Capucine Coulon, Olivia Domanski, Benjamin Constans, Max Gonzalez Estevez, Sophie Gautier, Luisa Marsili, Yasmine Ould Hamoud, Augustin Coisne, Hélène Ridon, Anne-Sophie Polge, Stéphanie Mouton, Yasmine Haddad, Francis Juthier, Mouhamed Moussa, Claire Mounier Vehier, Gilles Lemesle, Guillaume Schurtz, Charles Garabedian, Mercedes Jourdain, Sandro Ninni, François Brigadeau, David Montaigne, Nicolas Lamblin, Louise Ghesquiere
BACKGROUND: Cardiovascular diseases (CVDs) are currently the leading cause of maternal death in Western countries. Although multidisciplinary cardio-obstetric teams are recommended to improve the management of pregnant women with CVD, data supporting this approach are scarce. AIMS: To describe the characteristics and outcomes of pregnant patients with CVD managed within the cardio-obstetric programme of a tertiary centre. METHODS: We included every pregnant patient with history of CVD managed by our cardio-obstetric team between June 2017 and December 2019, and collected all major cardiovascular events (death, heart failure, acute coronary syndromes, stroke, endocarditis and aortic dissection) that occurred during pregnancy, peripartum and the following year...
April 12, 2024: Archives of Cardiovascular Diseases
https://read.qxmd.com/read/38643759/continuous-fetal-cardiac-monitoring-during-fetoscopic-myelomeningocele-repair-and-relationship-to-spectral-doppler-changes
#27
JOURNAL ARTICLE
Stephanie A Eyerly-Webb, Lisa Howley, Clifton O Brock, Joseph B Lillegard, James Fisher, Benjamin Reynolds, Emily F Barthel, Eric Dion, Saul Snowise
INTRODUCTION: No evidence-based protocols exist for fetal cardiac monitoring during fetoscopic myelomeningocele (fMMC) repair and intraprocedural spectral Doppler data is limited. We determined the feasibility of continuous fetal echocardiography during fMMC repair and correlated Doppler changes with qualitative fetal cardiac function during each phase of fMMC repair. METHODS: Patients undergoing fMMC repair had continuous fetal echocardiography interpreted in real-time by pediatric cardiology...
April 20, 2024: Fetal Diagnosis and Therapy
https://read.qxmd.com/read/38643271/analysis-of-the-role-of-perfusion-mechanical-and-electrical-stimulation-in-bioreactors-for-cardiac-tissue-engineering
#28
REVIEW
Jorge Bravo-Olín, Sabina A Martínez-Carreón, Emmanuel Francisco-Solano, Alvaro R Lara, Nohra E Beltran-Vargas
Since cardiovascular diseases (CVDs) are globally one of the leading causes of death, of which myocardial infarction (MI) can cause irreversible damage and decrease survivors' quality of life, novel therapeutics are needed. Current approaches such as organ transplantation do not fully restore cardiac function or are limited. As a valuable strategy, tissue engineering seeks to obtain constructs that resemble myocardial tissue, vessels, and heart valves using cells, biomaterials as scaffolds, biochemical and physical stimuli...
April 20, 2024: Bioprocess and Biosystems Engineering
https://read.qxmd.com/read/38642906/optimizing-clinical-outcomes-for-bronchoscopic-lung-volume-reduction-with-zephyr%C3%A2-valves
#29
REVIEW
T David Koster, Pallav L Shah, Arschang Valipour, Gerard J Criner, Felix J F Herth, Richard Sue, Douglas K Hogarth, Ralitza T Martin, Amit K Mahajan, Raed Alalawi, Lisa Kopas, Avi Cohen, Douglas E Wood, Jonathan Kurman, Narinder S Shargill, Mark Dransfield, Dirk-Jan Slebos, Michael Perch
Bronchoscopic lung volume reduction treatment with Zephyr one-way valves is an effective guideline-based treatment option for patients with severe emphysema and hyperinflation. However, in some cases the treatment response is less than anticipated or there might be a loss of initial treatment effect. Reasons for the lack of response can include incorrect assessment of collateral ventilation, improper valve placement, or patient related factors. Loss of initial benefit can be due to granulation tissue formation and subsequent valve dysfunction, or there may be side effects such as excessive coughing or infectious problems...
April 18, 2024: Respiratory Medicine
https://read.qxmd.com/read/38642224/current-management-of-tricuspid-regurgitation-a-focus-on-the-spiral-suspension-approach
#30
REVIEW
Kiyoyuki Eishi, Junichiro Eishi, Ichiro Matsumaru, Mizuki Sumi, Kikuko Obase, Takashi Miura
The indication for surgery for tricuspid regurgitation (TR) has reached a major turning point. It has become clear that the presence of moderate or severe TR alone worsens the prognosis of life, and the previous guidelines of Japanese Circulation Society, in which the indication for surgery was recommended at the timing of "right heart failure difficult to treat medically," now recommends surgery with a trigger of "repeated right heart failure" in the 2020 edition. In addition, a new repair technique targeting at subvalvular structure has been developed for end-stage TR to overcome a high TR recurrence rate that is associated with severe right ventricular enlargement and leaflet tethering...
April 20, 2024: General Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38641994/gm1-gangliosidosis-type-ii-results-of-a-10-year-prospective-study
#31
JOURNAL ARTICLE
Precilla D'Souza, Cristan Farmer, Jean M Johnston, Sangwoo T Han, David Adams, Adam L Hartman, Wadih Zein, Laryssa A Huryn, Beth Solomon, Kelly King, Christopher P Jordan, Jennifer Myles, Elena-Raluca Nicoli, Caroline E Rothermel, Yoliann Mojica Algarin, Reyna Huang, Rachel Quimby, Mosufa Zainab, Sarah Bowden, Anna Crowell, Ashura Buckley, Carmen Brewer, Debra S Regier, Brian P Brooks, Maria T Acosta, Eva H Baker, Gilbert Vézina, Audrey Thurm, Cynthia J Tifft
PURPOSE: GM1 gangliosidosis (GM1) a lysosomal disorder caused by pathogenic variants in GLB1, is characterized by relentless neurodegeneration. There are no approved treatments. METHODS: Forty-one individuals with type II (late-infantile and juvenile) GM1 participated in a single-site prospective observational study. RESULTS: Classification of 37 distinct variants using ACMG criteria resulted in the upgrade of six and the submission of four new variants...
April 16, 2024: Genetics in Medicine: Official Journal of the American College of Medical Genetics
https://read.qxmd.com/read/38641756/self-expanding-valves-more-beneficial-than-balloon-expandable-valves-in-patients-with-a-small-aortic-annulus
#32
JOURNAL ARTICLE
Karina Huynh
No abstract text is available yet for this article.
April 19, 2024: Nature Reviews. Cardiology
https://read.qxmd.com/read/38641628/nonbacterial-thrombotic-endocarditis-of-mitral-valve-associated-with-a-lymphoproliferative-malignancy-case-report-and-literature-review
#33
JOURNAL ARTICLE
Fabiana Duarte, Maria Inês Barradas, Ana Raquel Dias, Carlos Faria, Carina Machado, Carolina Pavão
BACKGROUND: Non-bacterial thrombotic endocarditis (NBTE) is a rare condition marked by sterile vegetations on cardiac valves, often linked to rheumatologic diseases, autoimmune disorders, and advanced solid malignancies. An early diagnosis and treatment of the associated clinical condition are mandatory, although they do not usually eliminate valvular vegetations, making anticoagulation essential to prevent embolic events. Despite variability, the prognosis of NBTE is usually unfavorable due to recurrent embolic events and the severity of the primary condition, typically advanced cancer...
April 19, 2024: Cardio-Oncology
https://read.qxmd.com/read/38641438/outcomes-and-treatment-strategy-of-transcatheter-aortic-valve-replacement-with-balloon-expandable-valve-in-borderline-size-annulus
#34
JOURNAL ARTICLE
Toshiaki Isogai, Nikolaos Spilias, Beka Bakhtadze, Nabil Sabbak, Kara J Denby, Habib Layoun, Ankit Agrawal, Shashank Shekhar, James J Yun, Rishi Puri, Serge C Harb, Grant W Reed, Amar Krishnaswamy, Samir R Kapadia
BACKGROUND: Candidates for transcatheter aortic valve replacement (TAVR) occasionally have a "borderline-size" aortic annulus between 2 transcatheter heart valve sizes, based on the manufacturer's sizing chart. Data on TAVR outcomes in such patients are limited. METHODS: We retrospectively reviewed 1816 patients who underwent transfemoral-TAVR with balloon-expandable valve (BEV) at our institution between 2016 and 2020. We divided patients into borderline and non-borderline groups based on computed tomography-derived annular measurements and compared outcomes...
March 28, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38641167/description-and-prevalence-of-ventricular-mitral-annular-disjunction-variation-of-normality-or-pathological-variant
#35
JOURNAL ARTICLE
Agata Krawczyk-Ożóg, Mateusz K Hołda, Jakub Batko, Kacper Jaśkiewicz, Artur Dziewierz, Barbara Zdzierak, Wojciech Zasada, Krzysztof Gil, Jakub Hołda
INTRODUCTION AND OBJECTIVES: The aim of this study was to investigate a new variation of the atrial wall-mitral annulus-ventricular wall junction along the mural mitral leaflet and commissures: the ventricular mitral annular disjunction (v-MAD). This new variant is characterized by spatial displacement of the mitral leaflet hinge line by more than 2 mm toward the left ventricle. METHODS: We examined a cohort of autopsied human hearts (n = 224, 21.9% females, 47...
April 17, 2024: Revista Española de Cardiología
https://read.qxmd.com/read/38639690/2-year-clinical-and-echocardiography-follow-up-of-transcatheter-mitral-valve-replacement-with-the-transapical-intrepid-system
#36
JOURNAL ARTICLE
Vinayak Bapat, Eric Weiss, Tanvir Bajwa, Vinod H Thourani, Pradeep Yadav, Jeremy J Thaden, D Scott Lim, Michael Reardon, Sean Pinney, David H Adams, Steven J Yakubov, Thomas Modine, Simon R Redwood, Antony Walton, Konstantinos Spargias, Angie Zhang, Michael Mack, Martin B Leon
BACKGROUND: Thirty-day outcomes with the investigational Intrepid transapical (TA) transcatheter mitral valve replacement (TMVR) system have previously demonstrated good technical success, but longer-term outcomes in larger cohorts need to be evaluated. OBJECTIVES: The authors sought to evaluate the 2-year safety and performance of the Intrepid TA-TMVR system in patients with symptomatic, ≥moderate-severe mitral regurgitation (MR) and high surgical risk...
April 1, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38639688/transcatheter-mitral-valve-replacement-the-road-to-redemption
#37
EDITORIAL
Nicolas M Van Mieghem
No abstract text is available yet for this article.
April 10, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38639687/6-months-follow-up-of-the-first-in-man-implantation-of-a-novel-tricuspid-flow%C3%A2-optimizer
#38
JOURNAL ARTICLE
Gian Paolo Ussia, Antonio Mangieri, Valeria Cammalleri, Kunal Sarkar, Damiano Regazzoli, Ottavia Cozzi, Mauro Gitto, Marco Francone, Andrea Fumero, Lucia Torracca, Renato M Bragato, Efrem Civilini, Bernhard Reimers, Antonio Colombo
No abstract text is available yet for this article.
March 23, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38639637/value-of-fetal-echocardiographic-examination-in-pregnancies-complicated-by-preterm-premature-rupture-of-membranes
#39
JOURNAL ARTICLE
Monika Pasieczna, Joanna Kuran-Ohde, Agnieszka Grzyb, Renata Bokiniec, Agata Wójcik-Sęp, Krzysztof Czajkowski, Joanna Szymkiewicz-Dangel
OBJECTIVES: Cardiopulmonary and infectious complications are more common in preterm newborns after preterm premature rupture of membranes (pPROM). Fetal echocardiography may be helpful in predicting neonatal condition. Our aim was to assess the cardiovascular changes in fetuses from pregnancies complicated by pPROM and possible utility in predicting the intrauterine or neonatal infection, and neonatal heart failure (HF). METHODS: It was a prospective study enrolling 46 women with singleton pregnancies complicated by pPROM between 18+0 and 33+6 weeks of gestation and followed until delivery...
April 22, 2024: Journal of Perinatal Medicine
https://read.qxmd.com/read/38639357/impact-of-new-onset-right-bundle-branch-block-after-transcatheter-aortic-valve-replacement-on-permanent-pacemaker-implantation
#40
JOURNAL ARTICLE
Shinnosuke Kikuchi, Yugo Minamimoto, Kensuke Matsushita, Tomoki Cho, Kengo Terasaka, Yohei Hanajima, Hidefumi Nakahashi, Masaomi Gohbara, Yuichiro Kimura, Shota Yasuda, Kozo Okada, Yasushi Matsuzawa, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Olivier Morel, Patrick Ohlmann, Keiji Uchida, Kiyoshi Hibi
BACKGROUND: A delayed and recurrent complete atrioventricular block (CAVB) is a life-threatening complication of transcatheter aortic valve replacement (TAVR). Post-TAVR evaluation may be important in predicting delayed and recurrent CAVB requiring permanent pacemaker implantation (PPI). The impact of new-onset right bundle-branch block (RBBB) after TAVR on PPI remains unknown. METHODS AND RESULTS: In total, 407 patients with aortic stenosis who underwent TAVR were included in this analysis...
April 19, 2024: Journal of the American Heart Association
keyword
keyword
66087
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.